Case–control analysis on metformin and cancer of the esophagus

被引:0
作者
Claudia Becker
Christoph R. Meier
Susan S. Jick
Michael Bodmer
机构
[1] University of Basel,Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, Basel University Hospital
[2] University Hospital Basel,Hospital Pharmacy
[3] Boston University School of Public Health,Boston Collaborative Drug Surveillance Program
[4] Bern University Hospital,Division of General Internal Medicine
来源
Cancer Causes & Control | 2013年 / 24卷
关键词
Esophageal cancer; Anti-diabetic drugs; Epidemiology; Case–control analysis; Metformin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1763 / 1770
页数:7
相关论文
共 237 条
[1]  
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]  
Bray F(2008)Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age J Natl Cancer Inst 100 1184-1187
[3]  
Center MM(1993)Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden Int J Cancer 54 402-407
[4]  
Ferlay J(2008)Continuing rapid increase in esophageal adenocarcinoma in England and Wales Am J Gastroenterol 103 2694-2699
[5]  
Ward E(2012)Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands Eur J Cancer 48 1624-1632
[6]  
Forman D(2010)Prevalence and trends in obesity among US adults, 1999–2008 JAMA 303 235-241
[7]  
Brown LM(2007)The burden of overweight and obesity in the Asia-Pacific region Obes Rev 8 191-196
[8]  
Devesa SS(2008)Obesity prevalence from a European perspective: a systematic review BMC Public Health 8 200-96
[9]  
Chow WH(2012)The worldwide diabetes epidemic Curr Opin Endocrinol Diabetes Obes 19 93-347
[10]  
Hansson LE(2011)Influence of obesity on the risk of esophageal disorders Nat Rev Gastroenterol Hepatol 8 340-319